Altre lingue Lincoln Pharmaceuticals Limited

Azioni

LINCOLN

INE405C01035

Mercato chiuso - Bombay S.E. Altri mercati azionari 06:14:48 12/07/2024			Variaz. 5gg	Var. 1 gen.
655,2 ^INR	-0,74%		+0,26%	+7,53%

20/05	Lincoln Pharmaceuticals Limited annuncia la nomina di un Direttore	CI
16/05	Lincoln Pharmaceuticals Limited riporta i risultati degli utili per il quarto trimestre terminato il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Lincoln Pharmaceuticals Limited Announces Director Appointments	20/05
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	16/05
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024	16/05
Lincoln Pharmaceuticals Limited Recommends Dividend for the Year Ended March 31, 2024	16/05
Lincoln Pharmaceuticals Limited Announces Pirabhai Suthar Will Cease to Be an Independent Director	30/03
Lincoln Pharmaceuticals Limited Announces Resignation of Meha Patel as Non-Executive Independent women Director	22/02
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08/02
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	02/11
Lincoln Pharmaceuticals Limited Declares Dividend for the Financial Year 2022-23	30/09/23
Lincoln Pharmaceuticals Limited Proposes Dividend for the Financial Year 2022-2023	06/09/23
Lincoln Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10/08/23
Lincoln Pharmaceuticals Limited Recommends A Dividend for the Year Ended March 31, 2023	25/05/23
Lincoln Pharmaceuticals Limited Approves the Resignation of Anand A. Patel from the Position of Whole Time Director as Well as Director of the Company	25/05/23
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	25/05/23
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	09/02/23
Lincoln Pharmaceuticals Limited Informs About Demise of Shri Ishwarlal Ambalal Patel Independent Director	05/12/22
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	10/11/22
Lincoln Pharmaceuticals Limited Appoints Trusha Shah as Company Secretary and Compliance Officer	10/11/22
Lincoln Pharmaceuticals Limited Approves to Declare Dividend for the Financial Year 2021-22	30/09/22
Lincoln Pharmaceuticals Limited Proposes to Declare Dividend for the Financial Year 2021-2022	06/09/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Lincoln Pharmaceuticals Limited

Azioni

LINCOLN

INE405C01035

Altre lingue

Filtri